Safety study of SAL0167 in healthy adults
Part of Hormones & metabolism clinical trials.
This study tests a new medication called SAL0167, which may help lower cholesterol, in healthy volunteers. It is a first-in-human study, meaning it looks at safety and how your body handles the drug, so it may not directly benefit your health but helps in developing a potential treatment for high cholesterol.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 65 years old
- Your weight should be at least 50 kg (110 lbs) for men and 45 kg (99 lbs) for women
- You must have a body mass index (BMI) between 19 and 28
- You need to be in generally good health, without significant medical conditions
- You cannot be taking most medications or supplements for at least 2 weeks before the study starts
- You must agree to use effective birth control, and not donate sperm or eggs, during the study and for 3 months after
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
This trial tests an investigational medicine (SHR-1918) added to your current statin therapy to see if it helps lower your LDL ('bad') cholesterol and triglycerides more than a placebo. It may be an option if you're on a statin but still have high cholesterol.
This study tests the safety and how the body handles a new medicine (SAL0140) in healthy people. It helps doctors find the right dose and check for side effects.
This study tests an experimental oral medication, SAL0137, to see if it can lower Lp(a) levels, a type of fat in the blood linked to heart disease. It may help people who have high Lp(a) and are at increased risk for heart attacks or strokes.
This study tests a new injected medicine called SAL0195 in healthy people to see if it is safe and how it works. It is especially for those with high levels of lipoprotein(a), a type of fat linked to heart disease.
This study tests an experimental drug (QLC7401) that may help lower LDL ('bad') cholesterol in people who already have high cholesterol or mixed hyperlipidemia. If you're on stable cholesterol medication but still need more lowering, this trial could offer another option.
Hear when a new Hyperlipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.